Your browser doesn't support javascript.
loading
Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation.
Lindsay, Julian; Sandaradura, Indy; Wong, Kelly; Arthur, Chris; Stevenson, William; Kerridge, Ian; Fay, Keith; Coyle, Luke; Greenwood, Matthew.
Affiliation
  • Lindsay J; Haematology Department, Royal North Shore Hospital, Sydney, Australia.
  • Sandaradura I; Department of Microbiology, St Vincent's Hospital, Sydney, Australia.
  • Wong K; University of New South Wales, Sydney, Australia.
  • Arthur C; Haematology Department, Royal North Shore Hospital, Sydney, Australia.
  • Stevenson W; Haematology Department, Royal North Shore Hospital, Sydney, Australia.
  • Kerridge I; Haematology Department, Royal North Shore Hospital, Sydney, Australia.
  • Fay K; Northern Blood Research Centre, Kolling Institute University of Sydney, Sydney, Australia.
  • Coyle L; Haematology Department, Royal North Shore Hospital, Sydney, Australia.
  • Greenwood M; Northern Blood Research Centre, Kolling Institute University of Sydney, Sydney, Australia.
J Antimicrob Chemother ; 72(12): 3414-3419, 2017 Dec 01.
Article in En | MEDLINE | ID: mdl-28961894

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Itraconazole / Chemoprevention / Serum / Antifungal Agents Type of study: Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Antimicrob Chemother Year: 2017 Type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Itraconazole / Chemoprevention / Serum / Antifungal Agents Type of study: Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Antimicrob Chemother Year: 2017 Type: Article Affiliation country: Australia